Competition is heating up, but questions remain about insurance coverage, drug pricing, copycat drugs and the role of pills in the space.

The stock market has continued to climb. But it's been tricky. Palantir, Robinhood and AMD lead big earnings this week.

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Eli Lilly delivered a stunning financial performance that exceeded even the most optimistic market expectations, driven by unprecedented demand for its ...

Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.

The AI chip darling already has the most cutting-edge products and the best customers. The next thing to do is to find more of them.